Literature DB >> 4812772

Proceedings: Bi-weekly chlorambucil treatment of chronic lymphocytic leukemia.

W H Knospe, V Loeb, C M Huguley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4812772     DOI： 10.1002/1097-0142(197402)33:2<555::aid-cncr2820330234>3.0.co;2-i

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  20 in total

1.  Coincidence of primary myelodysplastic syndrome and non-Hodgkin lymphoma.

Authors:  R Schulze; G Schlimok; D Renner
Journal:  Clin Investig       Date:  1992-12

Review 2.  New directions in the diagnosis and treatment of chronic lymphocytic leukaemia.

Authors:  Folke Schriever; Dieter Huhn
Journal:  Drugs       Date:  2003       Impact factor: 9.546

3.  MALT lymphoma of the paranasal sinuses and the hard palate: report of two cases and review of the literature.

Authors:  Stefan Tauber; Andreas Nerlich; Stephan Lang
Journal:  Eur Arch Otorhinolaryngol       Date:  2005-12-01       Impact factor: 2.503

4.  Treatment of feline gastrointestinal small-cell lymphoma with chlorambucil and glucocorticoids.

Authors:  Timothy J Stein; Mackenzie Pellin; Howard Steinberg; Ruthanne Chun
Journal:  J Am Anim Hosp Assoc       Date:  2010 Nov-Dec       Impact factor: 1.023

Review 5.  [Chronic lymphatic leukemia and hairy cell leukemia. Diagnosis and therapy].

Authors:  G Brittinger; K P Hellriegel; W Hiddemann
Journal:  Med Klin (Munich)       Date:  1997-06-15

Review 6.  On the architecture of translational research designed to control chronic lymphocytic leukemia.

Authors:  Michael Hallek
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

Review 7.  The role of combined fludarabine, cyclophosphamide and rituximab chemoimmunotherapy in chronic lymphocytic leukemia: current evidence and controversies.

Authors:  Alan P Skarbnik; Stefan Faderl
Journal:  Ther Adv Hematol       Date:  2016-12-01

8.  Inter- and intraindividual differences in oral chlorambucil pharmacokinetics.

Authors:  P Hartvig; B Simonsson; G Oberg; I Wallin; H Ehrsson
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

9.  DNA-synthesizing T and non-T cells in chronic lymphocytic leukemia.

Authors:  J A van der Woerd- de Lange; J Döhrmann; C Huber; P Schick; K Rauert; H Begemann
Journal:  Blut       Date:  1978-12-15

10.  Alemtuzumab in the treatment of fludarabine refractory B-cell chronic lymphocytic leukemia (CLL).

Authors:  Marco Montillo; Francesca Ricci; Sara Miqueleiz; Alessandra Tedeschi; Enrica Morra
Journal:  Biologics       Date:  2008-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.